PHAR

NASDAQ HEALTHCARE

Pharming Group NV

$11.21

$0.41 (+3.75%)

Live quote

52w: $9.62 – $21.34

Loading chart…

P/E Ratio2758.98

P/B Ratio28.39

EV/EBITDA—

Debt/Equity—

ROE1.03%

ROIC—

Revenue Growth26.56%

Gross Margin87.90%

Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.

Own PHAR? Track it here.

Create a free account to add PHAR to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account